Literature DB >> 1717578

Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.

M D McKisic1, A J Sant, F W Fitch.   

Abstract

Murine T lymphocytes recognize nominal Ag presented by class I or class II MHC molecules. Most CD8+ T cells recognize Ag presented in the context of class I molecules, whereas most CD4+ cells recognize Ag associated with class II molecules. However, it has been shown that a proportion of T cells recognizing class I alloantigens express CD4 surface molecules. Furthermore, CD4+ T cells are sufficient for the rejection of H-2Kbm10 and H-2Kbm11 class I disparate skin grafts. It has been suggested that the CD4 component of an anti-class I response can be ascribed to T cells recognizing class I determinants in the context of class II MHC products. To examine the specificity and effector functions of class I-specific HTL, CD4+ T cells were stimulated with APC that differed from them at a class I locus. Specifically, a MLC was prepared involving an allogeneic difference only at the Ld region. CD4+ clones were derived by limiting dilution of bulk MLC cells. Two clones have been studied in detail. The CD4+ clone 46.2 produced IL-2, IL-3, and IFN-gamma when stimulated with anti-CD3 mAb, whereas the CD4+ clone 93.1 secreted IL-4 in addition to IL-2, IL-3, and IFN-gamma. Cloned 46.2 cells recognized H-2Ld directly, whereas recognition of Ld by 93.1 apparently was restricted by class II MHC molecules. Furthermore, cytolysis by both clones 46.2 and 93.1 was inhibited by the anti-CD4 mAb GK1.5. These results demonstrate that CD4+ T cells can respond to a class I difference and that a proportion of CD4+ T cells can recognize class I MHC determinants directly as well as in the context of class II MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.

Authors:  H Plotnicky; J L Touraine
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

2.  CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function.

Authors:  M A Imro; C Castagneto; O Bosco; P Modena; L Lanza; F Puppo; G Filaci; F Indiveri; M Scudeletti
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

3.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.

Authors:  J Kirberg; A Baron; S Jakob; A Rolink; K Karjalainen; H von Boehmer
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

4.  Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways.

Authors:  G E Loss; C G Elias; P E Fields; R K Ribaudo; M McKisic; A J Sant
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

5.  Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules.

Authors:  J Kirberg; A Berns; H von Boehmer
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

6.  Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.

Authors:  R Schulz; A L Mellor
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

7.  Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.

Authors:  C Mongini; M Sánchez Lockhart; C I Waldner; E M Alvarez; M J Gravisaco; M I Roig; S E Hajos
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

8.  Activation of virus-specific major histocompatibility complex class II-restricted CD8+ cytotoxic T cells in CD4-deficient mice.

Authors:  M H Heemskerk; M W Schilham; H M Schoemaker; G Spierenburg; W J Spaan; C J Boog
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.